Skip to main content
Equibles
FZMD logo

FZMD · Fuse Medical, Inc. · Metrics

Track FZMD — free

Use FZMD with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research FZMD.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.03 +0.00 (+0.00%) At close · Nov 10
Rebalance outlook locked
Market Cap
$2.22M
Shares
73.90M
Volume · Nov 10 109.32K Avg daily vol (9 sessions) 66.34K

FZMD metrics

53 of 125 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$0.03
Market cap
$2.22M

Price action

23 metrics
Price change (1W)
—
Price change (30D)
+0.0%
Price change (3M)
+50.0%
Price change (6M)
+50.0%
Price change (YTD)
+50.0%
Price change (1Y)
-50.0%
Trailing year
Price change (5Y)
-95.1%
52-week high
$0.07
52-week low
$0.02
Change from 52-week high
-57.1%
Change from 52-week low
+50.0%
Annualized volatility
—
Annualized volatility (3M)
—
Implied volatility (30D)
—
IV rank (1Y)
—
IV percentile (1Y)
—
Beta
—
RSI (14D)
53.0
Price vs SMA 50
-18.7%
Price vs SMA 200
-69.6%
Avg volume (3M)
—
Relative volume
—
Average dollar volume
—

Company

3 metrics
Sector
Healthcare
Industry
Medical Devices
Shares outstanding
73.90M

Valuation

12 metrics
P / E (TTM)
0.6
Trailing earnings · reciprocal yield 179.4%
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
0.1×
reciprocal yield 830.2%
P / book
—
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
118.9
reciprocal yield 0.8%
Earnings yield
179.4%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
1.3×
reciprocal yield 74.8%
EV / revenue historical average (5Y)
1.3×
reciprocal yield 74.8%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
—

Profitability

9 metrics
Gross margin
65.6%
Operating margin
-0.7%
Trailing 12 months
Net margin
21.6%
Gross profit (TTM)
$12.07M
Operating profit (TTM)
−$121,583
Net income (TTM)
$3.98M
Trailing 12 months
Diluted EPS (TTM)
—
FCF margin
—
Effective tax rate
0.7%

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$0.00

Growth

11 metrics
Revenue growth YoY
+7.0%
Year over year
Net income growth YoY
—
Revenue (TTM)
$18.40M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+10.7%
Year over year · more shares
Revenue CAGR (3Y)
-6.6%
Revenue CAGR (5Y)
-6.7%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
+0.0%
FCF CAGR (3Y)
-48.5%
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
—
Return on assets
20.6%
Debt / equity
—
Current ratio
1.1
EBITDA (TTM)
$242,771
Free cash flow (TTM)
—
Quick ratio
0.3
Interest coverage
-0.6
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$253,378
Total assets
$19.32M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$18,641
Capital expenditures (TTM)
—
R&D (TTM)
—
SG&A (TTM)
$6.73M
Stock compensation (TTM)
$5,906
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

9 metrics
13F filers
—
13F filer change QoQ
—
Institutional ownership
—
Conviction holders (share of 13F filers)
—
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
—
Holder tenure
—
Price vs estimated holder cost
—

Ownership (registered funds)

1 metrics
Index-fund ownership
0.0%

Short interest

3 metrics
Short interest
0.0%
Latest settlement · 999+ days to cover
Days to cover
999+
Short-squeeze score
44 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 319016 Visit website Investor relations